Notably, although inflammation in some ADs (e.g., RA) initially localises to specific tissues (e.g., joints), abnormal immune cell crosstalk via BAFF/APRIL signalling facilitates systemic dissemination of activated B cells, enabling lymphoma development at non-inflammatory sites such as lymph nodes or spleen (85, 86). This evidence concerns the gene TNFSF13B and lymphoma.